BANK OF NOVA SCOTIA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF NOVA SCOTIA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2020$5,165,000
+1281.0%
59,200
+453.8%
0.01%
+600.0%
Q1 2016$374,000
+8.4%
10,6900.0%0.00%0.0%
Q4 2015$345,0000.0%10,6900.0%0.00%0.0%
Q3 2015$345,000
+28.7%
10,690
+64.5%
0.00%
+100.0%
Q2 2015$268,000
-7.9%
6,5000.0%0.00%0.0%
Q1 2015$291,0006,5000.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders